Bistratal Au@Bi2S3 nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer

Ruizhuo Ouyang,Penghui Cao,Pengpeng Jia,Hui Wang,Tianyu Zong,Chenyu Dai,Jie Yuan,Yuhao Li,Dong Sun,Ning Guo,Yuqing Miao,Shuang Zhou
DOI: https://doi.org/10.1016/j.bioactmat.2020.08.023
IF: 18.9
2021-02-01
Bioactive Materials
Abstract:To fabricate a highly biocompatible nanoplatform enabling synergistic therapy and real-time imaging, novel Au@Bi<sub>2</sub>S<sub>3</sub> core shell nanobones (NBs) (Au@Bi<sub>2</sub>S<sub>3</sub> NBs) with Au nanorods as cores were synthesized. The combination of Au nanorods with Bi<sub>2</sub>S<sub>3</sub> film made the Au@Bi<sub>2</sub>S<sub>3</sub> NBs exhibit ultrahigh photothermal (PT) conversion efficiency, remarkable photoacoustic (PA) imaging and high computed tomography (CT) performance; these Au@Bi<sub>2</sub>S<sub>3</sub> NBs thus are a promising nanotheranostic agent for PT/PA/CT imaging. Subsequently, poly(N-vinylpyrrolidone)-modified Au@Bi<sub>2</sub>S<sub>3</sub> NBs (Au@Bi<sub>2</sub>S<sub>3</sub>-PVP NBs) were successfully loaded with the anticancer drug doxorubicin (DOX), and a satisfactory pH sensitive release profile was achieved, thus revealing the great potential of Au@Bi<sub>2</sub>S<sub>3</sub>-PVP NBs in chemotherapy as a drug carrier to deliver DOX into cancer cells. Both <i>in vitro</i> and <i>in vivo</i> investigations demonstrated that the Au@Bi<sub>2</sub>S<sub>3</sub>-PVP NBs possessed multiple desired features for cancer therapy, including extremely low toxicity, good biocompatibility, high drug loading ability, precise tumor targeting and effective accumulation. Highly efficient ablation of the human liver cancer cell HepG2 was achieved through Au@Bi<sub>2</sub>S<sub>3</sub>-PVP NB-mediated photothermal therapy (PTT). As both a contrast enhancement probe and therapeutic agent, Au@Bi<sub>2</sub>S<sub>3</sub>-PVP NBs provided outstanding NIR-triggered multi-modal PT/PA/CT imaging-guided PTT and effectively inhibited the growth of HepG2 liver cancer cells <i>via</i> synergistic chemo/PT therapy.
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?